Anbio Biotechnology Files 2024 Annual Report
Ticker: NNNN · Form: 20-F · Filed: Apr 28, 2025 · CIK: 1982708
| Field | Detail |
|---|---|
| Company | Anbio Biotechnology (NNNN) |
| Form Type | 20-F |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, 20-f, biotechnology
TL;DR
Anbio Biotech filed its 2024 20-F, check it for biz updates.
AI Summary
Anbio Biotechnology filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, incorporated in the Cayman Islands and headquartered in Frankfurt am Main, Germany, operates in the in vitro & in vivo diagnostic substances sector. The filing was made on April 28, 2025, under SEC file number 001-42526.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Anbio Biotechnology's financial performance and business operations for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a foreign private issuer filing an annual report, the information provided is crucial for understanding the company's financial health and operational status, but the complexity of international filings can introduce additional risks.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- 20250428 — Filing Date (The date the 20-F was submitted to the SEC.)
Key Players & Entities
- Anbio Biotechnology (company) — Filer of the 20-F
- 001-42526 (company) — SEC file number
- 20241231 (date) — Fiscal year end
- 20250428 (date) — Filing date
- Cayman Islands (company) — Jurisdiction of incorporation
- Frankfurt am Main, Germany (company) — Business address
FAQ
What is the primary business of Anbio Biotechnology?
Anbio Biotechnology is involved in 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' as indicated by its Standard Industrial Classification code.
In which jurisdiction is Anbio Biotechnology incorporated?
Anbio Biotechnology is incorporated in the Cayman Islands.
What is the SEC file number for Anbio Biotechnology?
The SEC file number for Anbio Biotechnology is 001-42526.
When did Anbio Biotechnology's fiscal year end for this report?
The fiscal year ended on December 31, 2024.
Where is Anbio Biotechnology's principal business address?
Anbio Biotechnology's principal business address is in Frankfurt am Main, Germany.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on April 28, 2025 regarding Anbio Biotechnology (NNNN).